Indivior (NASDAQ:INDV) Share Price Breaks Above 50-Day Moving Average - Should You Sell?

Key Points

• Indivior shares rose above their 50-day moving average, reaching $37.00 before last trading at $35.25 on heavy volume. The stock’s 50-day and 200-day averages were approximately $35.24 and $35.62, respectively.
• Analyst sentiment remained broadly positive, with one Strong Buy, five Buy, and one Hold ratings; the consensus rating was Buy with a $45.50 price target.
• Indivior exceeded quarterly expectations, reporting $1.32 in EPS versus a $1.06 estimate and revenue of $356 million versus $329.35 million expected. The company also announced a special $8.13-per-share dividend for eligible shareholders.

Indivior PLC (NASDAQ:INDV - Get Free Report) shares crossed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $35.24 and traded as high as $37.00. Indivior shares last traded at $35.25, with a volume of 5,718,744 shares trading hands.

Wall Street Analyst Weigh In

A number of analysts have issued reports on INDV shares. Zacks Research upgraded shares of Indivior from a "hold" rating to a "strong-buy" rating in a research note on Friday, October 2nd. Craig Hallum reissued a "buy" rating and issued a $53.00 target price on shares of Indivior in a research report on Tuesday, August 4th. Weiss Ratings lowered shares of Indivior from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Thursday, September 24th. Finally, Barclays increased their price target on shares of Indivior from $43.00 to $45.00 and gave the stock an "overweight" rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of $45.50.

Indivior Stock Up 1.4%

The business has a 50-day simple moving average of $35.24 and a two-hundred day simple moving average of $35.62. The company has a market cap of $4.16 billion, a price-to-earnings ratio of 12.63 and a beta of 0.87.

Indivior (NASDAQ:INDV - Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.26. The company had revenue of $356.00 million during the quarter, compared to the consensus estimate of $329.35 million. Indivior had a negative return on equity of 283.11% and a net margin of 26.65%. As a group, equities analysts anticipate that Indivior PLC will post 3.66 earnings per share for the current year.

Indivior Dividend Announcement

The business also recently announced a special dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 30th will be issued a $8.13 dividend.

Insider Transactions at Indivior

In related news, CAO Woodrow D. Anderson bought 1,500 shares of the firm's stock in a transaction on Thursday, August 27th. The stock was purchased at an average price of $35.69 per share, with a total value of $53,535.00. Following the completion of the transaction, the chief accounting officer directly owned 27,638 shares of the company's stock, valued at $986,400.22. This trade represents a 5.74% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.74% of the stock is owned by insiders.

Hedge Funds Weigh In On Indivior

Institutional investors have recently modified their holdings of the company. Two Seas Capital LP raised its holdings in Indivior by 5.5% in the 3rd quarter. Two Seas Capital LP now owns 3,671,072 shares of the company's stock worth $131,608,000 after acquiring an additional 191,579 shares during the period. Assenagon Asset Management S.A. lifted its position in Indivior by 129.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 3,540,344 shares of the company's stock worth $126,921,000 after acquiring an additional 1,999,416 shares during the last quarter. Newtyn Management LLC acquired a new position in Indivior during the 2nd quarter worth $53,577,000. Hennion & Walsh Asset Management Inc. bought a new stake in Indivior during the second quarter valued at about $14,781,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Indivior during the second quarter valued at about $7,988,000. Institutional investors own 60.33% of the company's stock.

Indivior Company Profile

Indivior PLC NASDAQ: INDV is a global pharmaceutical company focused on developing and commercializing medicines for substance use disorders and serious mental health conditions. Its portfolio is centered on treatments for opioid use disorder, opioid overdose, and related medical needs.

The company's principal products include Sublocade, an extended-release buprenorphine injection for opioid use disorder; Suboxone, a buprenorphine and naloxone treatment available in film and other formulations; and Opvee, a nalmefene nasal spray intended for the emergency treatment of known or suspected opioid overdose.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.